Display Settings:

Format

Send to:

Choose Destination
J Empir Res Hum Res Ethics. 2008 Sep;3(3):57-68. doi: 10.1525/jer.2008.3.3.57.

Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?

Author information

  • 1Johns Hopkins Berman Institute of Bioethics and Bloomberg School of Public Health.

Abstract

CANCER PATIENTS OVERESTIMATE BENEFITS of early phase trials but studies have not reported what oncologists say to patients about trials. We audiotaped oncologists talking to cancer patients about Phase I or II trials and interviewed patients about the purpose and expected outcomes of trials presented to them. Oncologists gave mixed messages, saying Phase I trials measure safety and dosing, yet referring to trials as treatment with uncertain therapeutic effects. Seventeen percent of Phase I respondents said the trial's purpose related to safety/dosing (p = 0.017); 17% of Phase I respondents said the purpose was "to cure my cancer." Patients may find it important to believe trials offer significant benefit. Oncologists, while respecting patients' hopes, should be precise in their language, particularly regarding Phase I trials, distinguishing early stages of research from treatment.

PMID:
19385771
[PubMed]
PMCID:
PMC2861824
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk